SARS-CoV-2 Virus
7
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)
COMMUNITY - the COVID-19 Immunity Study
SARS-COV-2 Detection From Used Surgical Mask
SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
SARS-COV2 Pandemic Serosurvey and Blood Sampling
Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning